Multidrug resistance gene (MDR‐1) expression as a useful prognostic factor in patients with human hepatocellular carcinoma after surgical resection
Journal of Surgical Oncology2001Vol. 78(2), pp. 110–115
Citations Over Time
Atsushi Kato, Masaru Miyazaki, Satoshi Ambiru, Hideyuki Yoshitomi, Hiroshi Itô, Koji Nakagawa, Hiroaki Shimizu, Osamu Yokosuka, Nobuyuki Nakajima
Abstract
This study suggested that the measurement of the MDR-1 mRNA levels in HCC and nontumorous liver tissue might be a useful prognostic factor after surgical resection in patients with HCC.
Related Papers
- → Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?(2018)22 cited
- Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.(2003)
- Spontaneous rupture of hepatocellular carcinoma.(2002)
- Pathology of hepatocellular carcinoma(2006)
- The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.(1997)